1
|
Guerrero Tinoco GA, Espitaleta Vergara Z, Daniels García MJ, Domínguez-Vargas A. Ambulatory blood pressure monitoring in pediatric patients with sickle cell anemia. Blood Press Monit 2024; 29:9-14. [PMID: 37702734 DOI: 10.1097/mbp.0000000000000677] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 09/14/2023]
Abstract
INTRODUCTION Sickle cell anemia (SCA) is a hemoglobinopathy presenting severe endothelial damage associated with increased prevalence of hypertension (HTN). Few studies have used ambulatory blood pressure monitoring (ABPM) in pediatric patients with SCA. The aim of this study was to characterize the ABPM profile in children with SCA. METHODS A retrospective cross-sectional study was conducted on all subjects <18 years of age with SCA who presented at a medical reference center in the city of Cartagena, Colombia. Anthropometric, clinical laboratory, treatment, and ABPM parameters, including ambulatory arterial stiffness index (AASI) were registered. RESULTS The study included 79 patients, of these, 23 (29%) children had normal BP, 49 (62%) had abnormal BP and 7 (9%) had HTN. Mean age was 10.5 ± 3.6 years and 44 (56%) cases were male. Forty-eight (60%) patients had pre-HTN. Masked HTN was present in 6 (8%) patients. One (1%) had ambulatory HTN, and another one (1%) had white coat HTN. The HTA group exhibited significantly higher systolic BP and diastolic BP compared to the other groups in 24-hour BP readings, daytime BP, and night-time BP ABPM parameters ( P < 0.05), except for daytime DBP ( P = 0.08). Mean AASI was 0.4 ± 0.2. The HTN group had the highest AASI value compared to the other groups ( P = 0.006). CONCLUSION Significant alterations in ABPM parameters are frequently observed in pediatric patients with SCA. The incorporation of ABPM, along with the assessment of AASI, is recommended for a comprehensive evaluation of cardiovascular and renal risk in SCA patients.
Collapse
|
2
|
Bahaidarah S, Alzahrani F, Alshinqiti M, Moria N, Alahwal F, Naghi K, Abdulfattah A, Alharbi M, Abdelmohsen G. Factors influencing blood pressure fluctuation in pediatric patients with sickle cell disease in Saudi Arabia: A retrospective single-center cohort study. Saudi Med J 2023; 44:655-660. [PMID: 37463716 PMCID: PMC10370385 DOI: 10.15537/smj.2023.44.7.20230251] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 04/10/2023] [Accepted: 06/07/2023] [Indexed: 07/20/2023] Open
Abstract
OBJECTIVES To investigate changes in blood pressure (BP) among pediatric patients with sickle cell disease (SCD) and determine the variables that might influence these changes. METHODS A total of 100 pediatric patients with SCD who followed up in the pediatric outpatient clinic were recruited for this retrospective cohort study. Clinical data included anthropometric measures, average systolic and diastolic BP recorded during multiple follow-up visits, hemoglobin (Hb) level, serum creatinine, and hemoglobin S percentage. Blood pressure measurements were categorized according to the guidelines of the American Academy of Pediatrics (AAP, 2017). RESULTS In this cohort, 68% of the patients had normal systolic BP, 13% had elevated systolic BP, 17% had stage 1 hypertension (HTN), while only 2% reported stage 2 HTN. Patients who were overweight had relatively high systolic BP compared to patients who were underweight (p=0.034) or had normal weight (p=0.023). The average systolic BP significantly correlates with body mass index (r= 0.377, p<0.001) and serum creatinine (r=0.369, p<0.001). CONCLUSION Pediatric overweight SCD patients exhibited higher average systolic BP than those underweight or normal weight. Body mass index and serum creatinine significantly influenced the average systolic BP more than the Hb level or Hb S percentage.
Collapse
Affiliation(s)
- Saud Bahaidarah
- From the Department of Pediatrics (Bahaidarah, Alzahrani, Abdelmohsen), King Abdulaziz University Hospital, from the Faculty of Medicine (Alshinqiti, Moria, Alahwal, Naghi, Abdulfattah, Alharbi) King Abdulaziz University, Jeddah, Kingdom of Saudi Arabia; and from the Department of Pediatrics (Abdelmohsen), Kasr Al Ainy School of Medicine, Cairo University, Cairo, Egypt.
| | - Fatma Alzahrani
- From the Department of Pediatrics (Bahaidarah, Alzahrani, Abdelmohsen), King Abdulaziz University Hospital, from the Faculty of Medicine (Alshinqiti, Moria, Alahwal, Naghi, Abdulfattah, Alharbi) King Abdulaziz University, Jeddah, Kingdom of Saudi Arabia; and from the Department of Pediatrics (Abdelmohsen), Kasr Al Ainy School of Medicine, Cairo University, Cairo, Egypt.
| | - Mohammed Alshinqiti
- From the Department of Pediatrics (Bahaidarah, Alzahrani, Abdelmohsen), King Abdulaziz University Hospital, from the Faculty of Medicine (Alshinqiti, Moria, Alahwal, Naghi, Abdulfattah, Alharbi) King Abdulaziz University, Jeddah, Kingdom of Saudi Arabia; and from the Department of Pediatrics (Abdelmohsen), Kasr Al Ainy School of Medicine, Cairo University, Cairo, Egypt.
| | - Nader Moria
- From the Department of Pediatrics (Bahaidarah, Alzahrani, Abdelmohsen), King Abdulaziz University Hospital, from the Faculty of Medicine (Alshinqiti, Moria, Alahwal, Naghi, Abdulfattah, Alharbi) King Abdulaziz University, Jeddah, Kingdom of Saudi Arabia; and from the Department of Pediatrics (Abdelmohsen), Kasr Al Ainy School of Medicine, Cairo University, Cairo, Egypt.
| | - Fahad Alahwal
- From the Department of Pediatrics (Bahaidarah, Alzahrani, Abdelmohsen), King Abdulaziz University Hospital, from the Faculty of Medicine (Alshinqiti, Moria, Alahwal, Naghi, Abdulfattah, Alharbi) King Abdulaziz University, Jeddah, Kingdom of Saudi Arabia; and from the Department of Pediatrics (Abdelmohsen), Kasr Al Ainy School of Medicine, Cairo University, Cairo, Egypt.
| | - Khalid Naghi
- From the Department of Pediatrics (Bahaidarah, Alzahrani, Abdelmohsen), King Abdulaziz University Hospital, from the Faculty of Medicine (Alshinqiti, Moria, Alahwal, Naghi, Abdulfattah, Alharbi) King Abdulaziz University, Jeddah, Kingdom of Saudi Arabia; and from the Department of Pediatrics (Abdelmohsen), Kasr Al Ainy School of Medicine, Cairo University, Cairo, Egypt.
| | - Ammar Abdulfattah
- From the Department of Pediatrics (Bahaidarah, Alzahrani, Abdelmohsen), King Abdulaziz University Hospital, from the Faculty of Medicine (Alshinqiti, Moria, Alahwal, Naghi, Abdulfattah, Alharbi) King Abdulaziz University, Jeddah, Kingdom of Saudi Arabia; and from the Department of Pediatrics (Abdelmohsen), Kasr Al Ainy School of Medicine, Cairo University, Cairo, Egypt.
| | - Mohammed Alharbi
- From the Department of Pediatrics (Bahaidarah, Alzahrani, Abdelmohsen), King Abdulaziz University Hospital, from the Faculty of Medicine (Alshinqiti, Moria, Alahwal, Naghi, Abdulfattah, Alharbi) King Abdulaziz University, Jeddah, Kingdom of Saudi Arabia; and from the Department of Pediatrics (Abdelmohsen), Kasr Al Ainy School of Medicine, Cairo University, Cairo, Egypt.
| | - Gaser Abdelmohsen
- From the Department of Pediatrics (Bahaidarah, Alzahrani, Abdelmohsen), King Abdulaziz University Hospital, from the Faculty of Medicine (Alshinqiti, Moria, Alahwal, Naghi, Abdulfattah, Alharbi) King Abdulaziz University, Jeddah, Kingdom of Saudi Arabia; and from the Department of Pediatrics (Abdelmohsen), Kasr Al Ainy School of Medicine, Cairo University, Cairo, Egypt.
| |
Collapse
|